Kara Cannon - Jul 24, 2024 Form 4 Insider Report for ENZO BIOCHEM INC (ENZ)

Role
Chief Executive Officer, Director
Signature
/s/ Kara Cannon
Stock symbol
ENZ
Transactions as of
Jul 24, 2024
Transactions value $
-$82,935
Form type
4
Date filed
7/24/2024, 07:50 PM
Previous filing
May 24, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENZ Common Stock Tax liability -$82.9K -70.9K -15.71% $1.17 380K Jul 24, 2024 Direct F1
holding ENZ Common Stock 45.1K Jul 24, 2024 401k
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On August 31, 2023, the Reporting Person was granted, as previously reported on Form 4, 215,210 Restricted Stock Units ("RSUs"), which vested on July 24, 2024. 70,885 shares of common stock were withheld by Enzo Biochem, Inc. to satisfy tax withholding requirements in connection with the vesting of such RSUs.